These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Postoperative radiotherapy for stage II or III non-small-cell lung cancer using the surveillance, epidemiology, and end results database. Lally BE, Zelterman D, Colasanto JM, Haffty BG, Detterbeck FC, Wilson LD. J Clin Oncol; 2006 Jul 01; 24(19):2998-3006. PubMed ID: 16769986 [Abstract] [Full Text] [Related]
4. Impact of postoperative radiation therapy on survival in patients with complete resection and stage I, II, or IIIA non-small-cell lung cancer treated with adjuvant chemotherapy: the adjuvant Navelbine International Trialist Association (ANITA) Randomized Trial. Douillard JY, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe MA, Adjuvant Navelbine International Trialist Association. Int J Radiat Oncol Biol Phys; 2008 Nov 01; 72(3):695-701. PubMed ID: 18439766 [Abstract] [Full Text] [Related]
11. [Multivariate survival analysis of 899 patients with non-small cell lung cancer after complete resection]. Wei WD, Wen ZS, Su XD, Lin P, Rong TH, Chen LK. Ai Zheng; 2007 Nov 15; 26(11):1231-6. PubMed ID: 17991324 [Abstract] [Full Text] [Related]
12. Re-evaluation of the role of postoperative radiotherapy and the impact of radiation dose for non-small-cell lung cancer using the National Cancer Database. Corso CD, Rutter CE, Wilson LD, Kim AW, Decker RH, Husain ZA. J Thorac Oncol; 2015 Jan 15; 10(1):148-55. PubMed ID: 25325781 [Abstract] [Full Text] [Related]
14. Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, Somerfield MR, Brouwers MC, Darling G, Ellis PM, Gaspar LE, Pass HI, Spigel DR, Strawn JR, Ung YC, Shepherd FA, Cancer Care Ontario, American Society of Clinical Oncology. J Clin Oncol; 2007 Dec 01; 25(34):5506-18. PubMed ID: 17954710 [Abstract] [Full Text] [Related]
15. Effect of age on survival of clinical stage I non-small-cell lung cancer. Sigel K, Bonomi M, Packer S, Wisnivesky J. Ann Surg Oncol; 2009 Jul 01; 16(7):1912-7. PubMed ID: 19408051 [Abstract] [Full Text] [Related]
16. [Postoperative radiotherapy for non-small cell lung cancer: evidence based data and clinical practice]. Kepka L, Bujko K. Pneumonol Alergol Pol; 2007 Jul 01; 75(3):256-61. PubMed ID: 17966101 [Abstract] [Full Text] [Related]
17. Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery. Caglar HB, Baldini EH, Othus M, Rabin MS, Bueno R, Sugarbaker DJ, Mentzer SJ, Jänne PA, Johnson BE, Allen AM. Cancer; 2009 Sep 15; 115(18):4156-66. PubMed ID: 19551884 [Abstract] [Full Text] [Related]
18. Propensity score-matching analysis of postoperative radiotherapy for stage IIIA-N2 non-small cell lung cancer using the Surveillance, Epidemiology, and End Results database. Wei S, Xie M, Tian J, Song X, Wu B, Liu L. Radiat Oncol; 2017 Jun 13; 12(1):96. PubMed ID: 28610591 [Abstract] [Full Text] [Related]
19. Morbidity, mortality, and long-term survival after sleeve lobectomy for non-small cell lung cancer. Yildizeli B, Fadel E, Mussot S, Fabre D, Chataigner O, Dartevelle PG. Eur J Cardiothorac Surg; 2007 Jan 13; 31(1):95-102. PubMed ID: 17126556 [Abstract] [Full Text] [Related]
20. Localized non-small cell lung cancer: adjuvant radiotherapy in the era of effective systemic therapy. Bogart JA, Aronowitz JN. Clin Cancer Res; 2005 Jul 01; 11(13 Pt 2):5004s-5010s. PubMed ID: 16000604 [Abstract] [Full Text] [Related] Page: [Next] [New Search]